When was Roncadelle Operations founded?

Roncadelle Operations was founded in 2019.

Where is Roncadelle Operations located?

Roncadelle Operations is headquartered in Castel Mella, Italy.

How many employees does Roncadelle Operations have?

As of Jun 30, 2026, the latest employee count at Roncadelle Operations is 39.

Is Roncadelle Operations a funded company?

Roncadelle Operations is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does Roncadelle Operations rank among its competitors?

Roncadelle Operations ranks 27th amongst 83 active competitors, of which 21 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Stable Pharma, which secured an undisclosed amount in May, 2026.

Who are the top competitors of Roncadelle Operations?

Roncadelle Operations' top competitors include Crossject, Xeris Pharmaceuticals and KORU Medical Systems. Among them, Stable Pharma secured the most recent funding round in May, 2026.

Roncadelle Operations - 2026 Company Profile & Competitors

Roncadelle Operations is an unfunded company based in Castel Mella (Italy), founded in 2019. It operates as a Developer of syringes for drug delivery. Roncadelle Operations has not raised any funding yet. The company has 83 active competitors, including 21 funded and 8 that have exited. Its top competitors include companies like Crossject, Xeris Pharmaceuticals and KORU Medical Systems.

Company Details

Developer of syringes for drug delivery. The company offers a range of safety syringes and needle protection systems for pre-filled syringes for drug delivery.

Website: roncadelle-operations.com
Email ID: *****@roncadelle-operations.com
Phone Number: +39 **********

Key Metrics

Founded Year

2019

Location

Castel Mella, Italy

Stage

Unfunded

Ranked

27^th among 83 active competitors

Employee Count

39 as on Jun 30, 2026

Similar Companies

KORU Medical Systems & 57 more

View Roncadelle Operations' full profile

Roncadelle Operations has not raised any funding rounds yet.

Roncadelle Operations' employee count trend

Roncadelle Operations has 39 employees as of Jun 26. Here is Roncadelle Operations's employee count trend over the years:

Employee count trend for Roncadelle Operations

Uncover Roncadelle Operations' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Roncadelle Operations include Crossject, Xeris Pharmaceuticals and KORU Medical Systems. Here is the list of Top 10 competitors of Roncadelle Operations, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Crossject 2001, Dijon (France), Public	Needle-free self-injectable drugs	$40.3M	Rothschild & Co, GSK & 5 others	60/100
2nd	Xeris Pharmaceuticals 2005, Chicago (United States), Public	Developer of liquid-stable injectables for the delivery of drugs	$155M	Redmile Group, Central Texas Angel Network ... & 19 others	60/100
3rd	KORU Medical Systems 1980, City of Orange (United States), Public	Manufacturer of infusion systems and accessories for subcutaneous drug administration	-	-	55/100
4th	Stable Pharma 2011, Bath (United Kingdom), Series B	Developer of technology to store and deliver stable drugs and vaccines	$5M	Ascension, Crowdcube & 78 others	54/100
5th	Owen Mumford 1952, Oxford (United Kingdom), Acquired	Disposables for drug delivery and capillary blood sampling in a variety of therapeutic areas	-	Europa	52/100
6th	Retractable Technologies 1989, Little Elm (United States), Public	Provides portfolio of smart syringes and needles to prevent from needle-stick injuries	-	USAGov	51/100
7th	Ascilion 2012, Stockholm (Sweden), Series A	Developer of needles for drug delivery and fluid extraction	$2.23M	Nordstjernan, Marinvest & 2 others	48/100
8th	Flat Medical 2015, Oakland (United States), Series C	Manufacturer of epidural injection	-	Taiwania Capital, National Development Council ... & 4 others	46/100
9th	Windgap Medical 2011, Boston (United States), Series B	Provider of drug delivery autoinjector for the treatment of anaphylaxis	$76.7M	Taiwania Capital, SKK & 12 others	44/100
10th	SHL 1989, Zug (Switzerland), Funding Raised	Developer and manufacturer of autoinjectors and drug delivery system solutions	-	EQT, Athos Capital	44/100
27th	Roncadelle Operations 2019, Castel Mella (Italy), Unfunded	Developer of syringes for drug delivery	-	-	30/100